PEspeaks

Jul 30, 2015
The American Medical Association invested heavily in DC influence in the first two quarters of 2015. PhRMA wasn't far behind. Casey McDonald reports.
Jul 23, 2015
With biopharma companies increasingly accused of bankrupting the health care system with high prices, news that ICER has received a $5.2 million grant to expand its analyses of drug cost-effectiveness could be a game changer, writes Jill Wechsler.
Jul 22, 2015
Amgen and Sandoz received a decision from the U.S. Court of Appeals for the Federal Circuit in Washington on Tuesday. PharmExec spoke with legal and biosimilar experts for their initial reactions.
Jul 16, 2015
FDA has launched the process for reauthorizing the Prescription Drug User Fee Act (PDUFA), setting the stage for FDA to hear the views of patient, consumer and health professional representatives. Jill Wechsler reports.
Jul 15, 2015
There are evident challenges for pharma in the ongoing Greek crisis. But, writes Reflector, there are some less evident challenges which may, over time, prove to be more difficult for the industry to cope with.
Jul 14, 2015
Casey McDonald looks at the Twitter reaction to the Celgene–Receptos deal and to this week's other pharma news.
Jul 09, 2015
The budget increase for NIH brought strong support from the biomedical research community and medical societies across the board. Jill Wechsler reports.
Jun 30, 2015
Pharmaceutical Executive
Amid the release Pharm Exec's Emerging Pharma Leaders 2015, William Looney considers what will determine true leadership in big Pharma in the years ahead.
Jun 23, 2015
William Looney looks at the key predictions from EvaluatePharma's World Preview 2015, launched at last week's BIO International Convention.
Jun 23, 2015
Applied Clinical Trials
Conversely, social media discussions about study requirements and procedures may discourage participation and undermine study integrity, according to experts at last week’s Drug Information Association (DIA) annual meeting in Washington, D.C.